'0 mg kg' diaporamas de présentation

Anesthesia for Congenital Heart Disease

Anesthesia for Congenital Heart Disease. Glynne D. Stanley MB.ChB. FRCA. Introduction. Appropriate to distinguish between: Congenital cardiac surgery Non-cardiac surgery for patients with congenital cardiac disease. Congenital Cardiac Surgery. General Principles: Pre-operative management

1.24k views • 59 slides

Menopause

830 views • 54 slides

Menopause

836 views • 54 slides

Recovery from NMBA : problems and solutions

Recovery from NMBA : problems and solutions. Wirat Wasinwong Anesthesia department Faculty of Medicine Prince of Songkla University. Muscle relaxant. 1912 : curare 1970s : pancuronium 1980s : vecuronium, cisatracurium, mivacurium, rocuronium rapacuronium. Ideal muscle relaxant. Onset

607 views • 46 slides

INOTROPES IN CARDIOGENIC SHOCK

role of Inotropes and Vasodilators in cardiogenic shock

2.36k views • 45 slides

RSI: Rapid Sequence Intubation What, When, Where, Why & How

877 views • 37 slides

RSI: Rapid Sequence Intubation What, When, Where, Why & How

1.3k views • 37 slides

Paul J. Davis, MD Shaker A. Mousa, PhD

NANOTETRAC TARGETS THE THYROID HORMONE RECEPTOR ON INTEGRIN a v b 3 TO PROMOTE APOPTOSIS, DISRUPT CELL DEFENSE PATHWAYS AND BLOCK ANGIOGENESIS. Paul J. Davis, MD Shaker A. Mousa, PhD

375 views • 37 slides

DHS/HIV/ARV Rx/PP

HIV/AIDS Opportunistic Infection Update David H. Spach, MD Medical Director Northwest AIDS Education and Training Center Associate Professor of Medicine Division of Infectious Diseases University of Washington, Seattle. DHS/HIV/ARV Rx/PP. Opportunistic Infection: Update.

658 views • 36 slides

DHS/HIV/ARV Rx/PP

HIV/AIDS Opportunistic Infection Update David H. Spach, MD Medical Director Northwest AIDS Education and Training Center Associate Professor of Medicine Division of Infectious Diseases University of Washington, Seattle. DHS/HIV/ARV Rx/PP. Opportunistic Infection: Update.

497 views • 36 slides

DHS/HIV/ARV Rx/PP

HIV/AIDS Opportunistic Infection Update David H. Spach, MD Medical Director Northwest AIDS Education and Training Center Associate Professor of Medicine Division of Infectious Diseases University of Washington, Seattle. DHS/HIV/ARV Rx/PP. Opportunistic Infection: Update.

485 views • 36 slides

DHS/HIV/ARV Rx/PP

HIV/AIDS Opportunistic Infection Update David H. Spach, MD Medical Director Northwest AIDS Education and Training Center Associate Professor of Medicine Division of Infectious Diseases University of Washington, Seattle. DHS/HIV/ARV Rx/PP. Opportunistic Infection: Update.

373 views • 36 slides

Effects of IPLEX in Myotonic Dystrophy Type 1 (DM1)

Effects of IPLEX in Myotonic Dystrophy Type 1 (DM1). Muscle Study Group Annual Meeting 9/16/2008, Beaver Hollow, NY Richard T. Moxley, III, MD. Acknowledgements. University of Rochester Medical Center Principal investigator: Richard Moxley, III, MD

531 views • 30 slides

NEUROMUSCULAR BLOCKING AGENTS

NEUROMUSCULAR BLOCKING AGENTS. Key Concept. Muscle relaxation does not ensure unconsciousness, amnesia, or analgesia Neuromuscular blocking agents are used to improve conditions for tracheal intubation, to provide immobility during surgery, and to facilitate mechanical ventilation.

349 views • 25 slides

Probability of Microalbuminuria

1.0. Abnormal nocturnal pattern. 0.8. Normal nocturnal pattern. 0.6. Probability of Microalbuminuria. 0.4. P=0.01. 0.2. 0. 0. 12. 24. 36. 48. 60. 72. 84. Months. Lurbe E et al., New Engl J Med 2002. Antihypertensive treatment approaches in the Renin Angiotensin System.

302 views • 22 slides

Accumetrics, Inc. Amgen, Inc. AstraZeneca Pharmaceuticals LP Baxter Bayer Healthcare LLC

Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction Jessica L. Mega, MD; David A. Morrow, MD, MPH; Erika Ostor, MD; Maria Dorobantu, MD, PhD; Jie Qin, MS; Elliott M. Antman, MD; Eugene Braunwald, MD. Disclosures.

232 views • 11 slides

Accumetrics, Inc. Amgen, Inc. AstraZeneca Pharmaceuticals LP Baxter Bayer Healthcare LLC

Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction Jessica L. Mega, MD; David A. Morrow, MD, MPH; Erika Ostor, MD; Maria Dorobantu, MD, PhD; Jie Qin, MS; Elliott M. Antman, MD; Eugene Braunwald, MD. Disclosures.

287 views • 11 slides

Newtonian Mechanics

444 views • 11 slides

Effects of aqueous extract of Hibiscus sabdariffa L. calyces on liver marker enzymes of phenobarbitone-induced adult wis

Hibiscus sabdariffa is an annual dicotyledonous herbaceous shrub plant popularly known as “zobo” in Nigeria which is an indigenous edible medicinal plant used in Ayurvedic medicine in India, China and Thailand. The purpose of this studies is to investigate the effect of Hibiscus sabdariffa leaf extract on liver marker enzymes such as AST (aspartate aminotransferase), ALT (alanine aminotransferase) and ALP (alkaline phosphatase), for its hepatoprotective effect in phenobarbitone-induced rats. Phenobarbitone treated rats showed a significant increase (P<0.05) in the levels of circulatory AST, ALT and ALP. These changes were significantly decreased (P<0.05) in rats treated with HSEt and phenobarbitone. These results indicate that HSEt offers hepatoprotection by influencing the levels of liver markers in phenobarbitoneinduced rats and this could be due to its free radical scavenging property and the presence of natural antioxidants.

128 views • 10 slides

Use of KRN330, A Fully Human Antibody Against A33, in Combination with

Abstract ID #534. Use of KRN330, A Fully Human Antibody Against A33, in Combination with Irinotecan for Patients with Metastatic Colorectal Cancer (mCRC) J.C. Bendell, 1 J.L. Marshall, 2 J. Berlin, 3 H.S. Hochster, 4

123 views • 1 slides